Swiss RNA Therapeutics Summit – 26.1.2023, University of Bern, Switzerland

The Swiss RNA Therapeutics Summit brings together stakeholders in the field of RNA Therapeutics from academia, biotechnology, pharma, manufacturing, government, and regulatory bodies with the aim to join forces in this rapidly advancing field. Also, the workshop brings into together companies with potential future employees.

The idea of the workshop was born after a panel discussion on “RNA Drugs: Applications Beyond Vaccines” at the Swiss Biotech Day in May 2022 in Basel. The Swiss RNA Therapeutics Summit is a joint initiative of the National Center of Competence in Research (NCCR) “RNA & Disease: The Role of RNA in Disease Mechanisms” and the Swiss Biotech Association.

The first Swiss RNA Therapeutics Summit will take place on Thursday, January 26, 2023, from 08:30 – 18:00 at the UniS building of the University of Bern, which is located in close proximity to the Bern train station.

The program will consist of keynotes, panel discussions, presentations and a meet-the-talent session. The program is designed to leave enough time to network.

Of note, the following day (Friday, January 27, 2023) the traditional Swiss RNA Workshop takes place at the same venue.

We are grateful to our sponsors for their support for the summit.

Gold Sponsor:
Moderna Therapeutics – Pioneering mRNA technology
Silver Sponsors:
Bachem – Peptides and Oligonucleotides

Bern Economic Development Agency

Lonza – Enabling a healthier world

Roche – Doing now what patients need next

Skyhawk – Small molecule Therapeutics for Alternative modulation of RNA

Versameb – The next generation of RNA therapeutics
Bronze Sponsors:
Alithea Genomics – Large-scale RNA sequencing. For everyone
Alithea Genomics – Large-scale RNA sequencing. For everyone
Alnylam Pharmaceuticals – The leading RNAi therapeutics company

Axolabs – Serving Oligonucleotide Therapeutics

Biogen– Caring deeply. Working fearlessly. Changing lives.

CSL Behring – A global biotech leader

HAYA Therapeutics – Pioneering next-generation therapies for fibrotic disease

Microsynth – The Swiss DNA Company

Novartis – At Novartis, we are reimagining medicine

Click here for the list of speakers and panelists.
Click here for the program of the workshop.
Click here for registration.
Click here for information regarding the venue.
Click here for information regarding the organizers.
Click here for News.